
Soleno Therapeutics SLNO
$ 52.99
-0.01%
Quarterly report 2026-Q1
added 05-07-2026
Soleno Therapeutics EV/EBITDA Ratio 2011-2026 | SLNO
Annual EV/EBITDA Ratio Soleno Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 | -10.5 | -16.7 | -0.844 | 0.12 | -3.56 | -4.2 | -1.1 | 0.183 | -0.77 | -0.592 | 1.2 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 186 | -16.7 | 12.4 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 17.26 | -7.0 % | $ 181 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 1.34 | -17.79 % | $ 1.78 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.78 | -2.53 % | $ 477 M | ||
|
Agilent Technologies
A
|
27.4 | $ 112.09 | -1.02 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
-227 | $ 19.05 | 0.9 % | $ 552 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
70.5 | $ 139.97 | -2.28 % | $ 22.3 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
3.62 | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 19.83 | -3.22 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
15.5 | $ 94.74 | -2.0 % | $ 6.39 B | ||
|
Check-Cap Ltd.
CHEK
|
0.000843 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 419.82 | 0.16 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
627 | $ 1 043.89 | 0.19 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
-1.79 | $ 3.6 | -0.69 % | $ 333 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
14.3 | $ 18.46 | -2.48 % | $ 413 M | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 157.18 | -1.33 % | $ 7.79 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
-19.5 | $ 186.22 | -5.43 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
17.1 | $ 25.27 | -0.94 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-38.2 | $ 92.95 | -5.79 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 5.73 | -1.55 % | $ 239 M | ||
|
Personalis
PSNL
|
-4.87 | $ 6.47 | -3.64 % | $ 577 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 117.95 | 0.73 % | $ 9.73 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 49.3 | -6.89 % | $ 2.95 B | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 251.18 | -1.12 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 439.31 | -1.97 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 0.57 | -1.49 % | $ 205 M | ||
|
Celcuity
CELC
|
-32.4 | $ 134.9 | 0.13 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
60.2 | $ 331.34 | -0.56 % | $ 19.7 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 8.27 | -1.9 % | $ 1.79 B |